All tenders
75N93020C00004
ERMES Evaluation of Radiomitigative Efficacy and Safety of BP-C2
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93020C00004
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- ERMES Evaluation of Radiomitigative Efficacy and Safety of BP-C2
- Source
- USASpending (Federal)
- Source ID
- usa-75N93020C00004
Details
- Location
- United States
Summary
This is a research contract for the ERMES (Evaluation of Radiomitigative Efficacy and Safety) program to assess the efficacy and safety profile of BP-C2, a radiomitigative agent. The work involves clinical or preclinical evaluation of this pharmaceutical candidate's ability to mitigate radiation effects. The contract has been awarded to MEABCO INC.
Description
ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 Awarded to: MEABCO INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2020/05/01 12:00:00 AM UTC
- Closing date
- 2025/04/30 12:00:00 AM UTC
Estimated value
$6.3M USD
Classification
Normalized category
Other